NASDAQ:VRTX

Vertex Pharmaceuticals Stock News

etoro logo Buy VRTX
*Your capital is at risk
$428.34
+3.25 (+0.765%)
At Close: Jun 03, 2026
Galvin Gaustad and Stein LLC boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 44.8% during the undefined quarter, according to its most recent 13F filing with the Securiti
This selection of stocks offers interesting buys throughout industries -- from tech to healthcare. Many of these players are trading at bargain levels.
Generali Asset Management SPA SGR lifted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 41.8% during the undefined quarter, according to its most recent disclosure with the SEC.
Alphabet should continue to benefit from a strong AI tailwind in 2026. Vertex Pharmaceuticals has several growth drivers in the new year.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

2 Growth Stocks to Buy For 2026 and Beyond

08:00am, Tuesday, 30'th Dec 2025
Vertex could have several catalysts in 2026, helping it set a strong foundation for the future. DexCom is expanding its addressable market in order to help deal with some current challenges.
Amazon's profitability underscores the success of established and emerging growth sources. Vertex Pharmaceuticals is launching several new products, and more approvals could be around the corner.

Forget Moderna Stock, This is a Much Better Buy

10:10am, Saturday, 27'th Dec 2025
Moderna stock soared in the early stages of the pandemic, then struggled -- but in recent times, it's been on the rise. This other biotech has proven itself as a long-term winner.
Founders Financial Securities LLC boosted its holdings in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 154.7% during the third quarter, according to its most recent Form 13F filing with the S
Alpine Woods Capital Investors LLC decreased its stake in Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) by 21.0% during the undefined quarter, according to the company in its most recent Form 13F
Recently, Zacks.com users have been paying close attention to Vertex (VRTX). This makes it worthwhile to examine what the stock has in store.
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 44th Annual J.P. Mor
Exploring the Fund's Recent Portfolio Adjustments Vanguard Health Care Fund (Trades, Portfolio) recently submitted its N-PORT filing for the third quarter of 2
December's mixed performance for tech may be an early signal that leadership is narrowing, especially among the value-stretched stocks. Investors looking forward to 2026 may find better risk-adjusted
In the closing of the recent trading day, Vertex Pharmaceuticals (VRTX) stood at $449.52, denoting a -1.2% move from the preceding trading day.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE